US2948738A - Steroids and process for making same - Google Patents

Steroids and process for making same Download PDF

Info

Publication number
US2948738A
US2948738A US711163A US71116358A US2948738A US 2948738 A US2948738 A US 2948738A US 711163 A US711163 A US 711163A US 71116358 A US71116358 A US 71116358A US 2948738 A US2948738 A US 2948738A
Authority
US
United States
Prior art keywords
parts
volume
solution
ethylenedioxy
lactone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US711163A
Inventor
Reichstein Tadeus
Szpilfogel Stefan Antoni
David Adriaan Van Dorp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US2948738A publication Critical patent/US2948738A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Definitions

  • This invention provides a new D-homo-androstene compound, and derivatives thereof, as well as process for manufacturing same. More particularly this invention relates to the lactone of the 11 -11p-hydroxy-17-formyl- D-homo-androstadiene-Zi-one-18-acid of the formula:
  • Functional derivatives are those, which are formed with aldehydic and ketonic reagents, and are readily convertible into the compound of the above formula; more particularly acetals, ketals, e.g. ethylenedioxy derivatives, mercaptals, thioketals, enol derivatives, such as enol esters, enol ethers or enamines, hydrazones, semicarbazones, thiosemicarbazones, or the like.
  • lactone of the A -11p-hydroxy-17-forrnyl-D- homoandrostadiene-3-one-18-acid, or the functional derivatives thereof are key intermediates in the preparation of therapeutically valuable compounds containing a formyl group in the 13-portion, such as aldosterone or the 17ot-hydroxylated derivative thereof, which is described in our copending application, Serial No. 711,164 concurrently filed herewith.
  • the new D-homo-androstene of the invention may be converted into aldosterone according to the following procedure: After the D-homo-androstene compound has been converted into the 3-ethylenedioxy derivative thereof, in which the double bond in the 4-position is shifted into the 5-position, is, upon treatment of this 3-ethylenedioxy derivative of the lactone of A -llfi-hydroxy-l7-formyl-D-homo-androstadiene-3-one-l8-acid with sodium boron hydride, and esterification with benzoyl chloride, the benzoate .of the lactone of this compound is formed, which is further subjected to treatment with lithium aluminium hydride and esterification with benzoyl chloride.
  • the thus ob tained dibenzoate of the 113,18-cyc1osemiacetal of A llfi-hydroxy 17 hydroxymethyl 18 oxo 3 ethylenedioxy D homo androstadiene is oxidized first with osmium tetroxide and then with periodic acid to the dibenzoate of the 218,4,3-cyclosemiacetal of 4bfi-methyl- 1p formylmethyl 25 formyl-2a(3 hydroxy 2' oxopropyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10, lOaa-dodecahydrophenanthrene-4B-ol.
  • the formation of the latter may also be accomplished by treatment of the dibenzoate of the 115,18-cyclosemiacetal of A -IIp-hydroxy- 17 -hydroxymethyl-l 8-oxo-3-ethylenedioxy-D-homoice androstadiene with ozone, then with zinc in acetic acid!
  • the ring closure to the dibenzoate of the 1:1fi,18-cyclosem1- acetal of A -11,6,2l-dihydroxy-l8,20-dioxo-3-ethylenedioxy-pregnadiene may be accomplished by treatment with piperidine in glacial acetic acid.
  • the A 11B,17oc,21 trihydroxy 3,18,20 trioxo-preg-, nene may be prepared according to the process described in our copending application, Serial No. 711,164, filed concurrently herewith, for example by treating the dibenzoate of the 11,8,18-cyclosemiacetal of A -115,21: dihydroxy 18,20 dioxo 3 ethylenedioxy pregnadiene, referred to above, withhydrogen peroxide, splitting the 16,17a-epoxide ring with hydrogen bromide and re moving the bromo atom in the 16-position by treatment with Raney nickel.
  • the thus obtained dibenzoate of the 11,6,18-cyclosemiacetal of- A -11fl,17a,21-trihydroxy- 18,20-dioxo-3-ethylenedioxy-pregnene yields the desired carbonate.
  • the new lactone of A -11fl-hydroxy-l7-formyl-D- homoandrostadiene-3-one-18acid of this invention, or derivatives thereof may be prepared by treating the lactone of 4b? methyl 2B carboxy lfi formyl methyl 20a- (3' oxo propyl) 1,2,3,4,4aa,4b,5,6,7,9,10,10afi dodecahydrophenanthrene-4B-ol-7-one or a functional deriva-v tive thereof with ring closing reagent,-and, if desired, converting any res11lting,-functional derivative into the lactone of A -llB-hydroxy-l7formyl-D-homo-andror stadiene-S-one-lS-acid, and/or, if desired, converting the resulting lactone of A -1lfi-hydroxy-17-formyl-D-homoandrostadiene-Zl-one-l8-acid into
  • Functional derivatives of the starting material are more especially acetals or ketals, such as the 7-ethylenedioxy derivative, in which the double bond in the 8-position is shifted into the 8a-position.
  • a reagent suitable for bringing about the closure of the ring is particularly a mixture of piperidine with acetic acid.
  • the process of the invention may be carried out with racemates or optically active compounds.
  • the racemates may be separated into their antipodes by methods, in themselves known, e.g. by chemical or micro-biological methods.
  • the lactone of 4bfi-methyl-2fl-carboxy-lfi-formyl: methyl 2a (3 oxo propyl) l,2,3,4,4aa,4b,5,6,7,9, l0,loafi-dodecahydrophenanthrene-4fl-ol-7-one or a functional derivative thereof used as the starting material in the above reaction may be prepared according to the following procedure: 4b[3-methyl-2-hydroxymethylene-7: ethylenedioxy 1,2,3,4,4,aa,4b,5,6,7,8,10,l0a18 dodecahy drophenanthrenetp-ol-l-one, when condensed with acrolein, yields the 4bB-methyl-2 3-formy1-2a-(3'-oxo-propyl)- 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10,10au dodeca: hydrophenanthrene-4B-o1-l-on
  • the I 4aa,4b,5,6,7,8,10,10a;8 dodecahydrophenanthrene 1,4 ⁇ 3- diol formed is hydrogenated in the presence of a palladium catalyst and rearranged by dehydration with a solution of thionyl chloride in pyridine to the lactone of 4bfi methyl 2e carboxy 1,1 'formyl methylene- 2oz (3',3' dimethoxypropyl) 7 ethylenedioxy' 1,2,3, 4,4aa,4b,5,6,7,8,l0,la,8 7 dodecahydrophenanthrene 4/9- 01.
  • the starting material may also be used in the crude formwithout previous purification.
  • a hydrohalic acid e.g. hydrogen chloride in acetone
  • Example 5 parts of the 'lactone of 4bB-methyl-2B-carboxy-1,3- formyl methyl 20c (3',3' dimethoxy propyl) 7- ethylenedioxy l,2,3,4,4aa,4b,5,6,7,8,10,10a/3 dodecahydrophenanthrene-4B-ol are dissolved in 250 parts by volume of dry acetone, and, after addition of 1.65 parts by volume of hydrochloric acid of 36 percent strength, stirred for 3 minutes at room temperature.
  • the mixture is neutralized by the addition of 30 parts by volume of a l-molar aqueous sodium hydrogen carbonate solution, diluted with 2500 parts by volume of water, and thoroughly extracted with a mixture of methylene chloride and ether (1:3).
  • the organic layer is washed with water, dried with'sodium sulfate, filtered and evaporated in vacuo to dryness.
  • the oily residue which isthe crude lactone of 4b,?
  • methyl 2,3 carboxy 1B -formylmethyl 2o (3- oxo-propyl) 7 ethylenedioxy 1,2, 3,4,4'aa,4b,5,6,7,'8,10,10ap dodecahydrophenanthrene- 4,6 0], is dissolved in 450 parts by volume of benzene, mixed with 12 parts by volume of glacial acetic acid and 9 parts by volume of piperidine, and boiled for 1 /2 hours in an atmosphere of nitrogen in an apparatus provided with a water-separator. After cooling, the solution is washed with Water, sodium hydrogen carbonate, and water, dried with sodium sulfate, and evaporated under reduced pressure.
  • lactone of 4b 8-methyl-Zp-carboxy lfiformylmethyl 2oz (3,3' dimethoxy propyl) 7 ethylenedioxy l,2,3,4,4aa,4b,5,6,7,'8,10,10a/3 dodecahydrophe'nanthrene-4fl-ol used as the starting material, may beprepared as follows:
  • the reaction mixture is stirred for half an hour at a temperature of 0 to +3 C., a crystalline precipitate slowly forming.
  • the mixture is neutralized with a dilute solution of sodium methoxide in absolute methanol, the mixture is suction-filtered, and the crystals are Washed with cold methanol.
  • the pure 4bfi-methyl- 2B formyl 2a (3',3' -.dimethoxy propyl) 7 ethylenedioxy l,2,3,4,4a:z,4b,5,6,7,8,l0,10a,B dodecahydrophenanthrene-4 3-ol-1-one melting at 188 C.
  • the reaction mixture is stirred for 2 hours at room temperature under nitrogen, then'poured on to 1000 parts of ice water, thoroughly shaken and the aqueous phase extracted three times with 750 parts by volume of a mixture of benzene and ether (1:1) each time.
  • the mixture is filtered from the catalyst, through a thin layer of Super Cel, the filter is washed with alcohol, and the filtrate is evaporated to dryness under reduced pressure.
  • the crystalline residue is recrystallized from a mixture of ethyl acetate and petroleum ether.
  • the resulting lactone of 4b1S-methyl-2B- carboxy 1;? ethoxy vinyl 20c (P/,3 dimethoxypropyl) 7 ethylenedioxy 1,2,3,4,4au,4b,5,6,7,8,10, 10a,8 dodecahydrophenanthrene 111,4 3 diol melts at 184-186 C.
  • a solution of 3.3 parts of the lactone of 4b,8-methyl- 25 carboxy 1B ethoxy vinyl 2a (3,3' dimethoxy propyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8, 10,10a/8 dodecahydrophenanthrene 10:,45 diol in 135 parts by volume of anhydrous pyridine is mixed with .38 parts by volume of a 2-molar solution of purest thionyl chloride in anhydrous pyridine at C. in an atmosphere of nitrogen in the course of 2 minutes. After stirring for 15 minutes at 0 C.
  • reaction mixture is poured on to 700 parts by volume of a cold 0.5-molar solution of sodium hydrogen carbonate and washed with 1000 parts by volume of methylene chloride.
  • the .mixture is thoroughly agitated and the organic layer is washed with icecold 0.5-molar sodium hydrogen carbonate solution and with cold water, dried with sodium sulfate, and after filtration'the solution is evaporated .to dryness under reduced pressure.
  • the lactone of the d,l-A -l1fihydroxy-l7-formyl D- homo-androstadiene-3-one-l8-acid of this invention or a functional derivative. thereof may be converted into ,aldosterone according to the following method: A solution of 6.2 parts of the lactone of d,l-A -'llB-hydroxy-Ii-ethylenedioxy 17 -,formy1 D homo androstadiene 18- acid in 200 parts by volume of alcohol is stirred for 16. hours at room temperature after the addition of 0.8 part of sodium boron hydride.
  • the mixture is poured on to 340 parts by volume of ice water and washed with 100 parts by volume of methylene chloride.
  • the mixture is extracted twice more with 150 parts by volume of methylene chloride each time, the extracts are washed with cold l-molar sodium hydrogen carbonate solution, water, dilute hydrochloric acid and again with Water, dried with sodium sulfate and evaporated in vacuo.
  • the residue is dissolved in 20 parts by volume of benzene and after a short treatment with active charcoal is filtered through a small column of alumina.
  • the crude reaction product After drying the ethyl acetate solution with sodium sulfate, filtering and evaporating under reduced pressure to dryness, the crude reaction product is subjected to ring closure by boiling a solution in 450 parts by volume of benzene, mixed with 12 parts by volume of glacial acetic acid and 9 parts by volume of piperidine, for one and one half hours in an atmosphere of nitrogen in an apparatus provided with a water separator. After cooling, the solution is washed with water, sodium hydrogen carbonate and water, dried over sodium sulfate and evaporated under reduced pressure.
  • 1 part of the compound so obtained is dissolved in 50 parts by volume of pure methanol and, after the addition of a solution of 0.01 part of potassium hydroxide in parts by volume of methanol and 1 part of a 2 percent palladium-carbon catalyst, the mixture is agitated in an atmosphere of hydrogen until 1 mol of hydrogen has been taken up.
  • the catalyst is removed by filtration, washed with methanol, the solution is neutralized by the addition of 0.01 part of glacial acetic acid and concentrated by evaporation in vacuo.
  • the residue is taken up in chloroform, the chloroform solution is washed with water, dried with sodium sulfate and evaporated to dryness in vacuo.
  • 1 part of the dibenzoate of 115,18-cyclosemiacetal of d,l-A -l1fi,21-dihydroxy 18,20-dioxo-3 ethylenedioxypregnadiene is dissolved in parts by volume of methanol and treated with a solution of 0.2 part of potassium carbonate in 2 parts by volume of water and with 5 parts by volume of a hydrogen peroxide solution of 30 percent strength.
  • the reaction mixture is allowed to stand at 0 C. for 48 hours, 2 parts of solid potassium monophosphate are then added and the mixture is concentrated at a bath temperature of 25 C. until about 20 parts by volume are left.
  • the residue is mixed with 100 parts by volume of water and extracted with a total of 200 parts by volume of methylene chloride in 3 portions. The extracts are thoroughly washed with water, dried and evaporated.
  • the crude, partially saponified product thus obtained is rebenzoylated with pyridine and benzoyl chloride with the use of chloroform as diluent.
  • the resulting dibenzoate of 11,53,18-cyc1osemiacetal of d,l-A -ll;3,21-dihydroxy-I6,17a-oxido-18,20-dioxo 3 ethylenedioxy pregnene is dissolved in 50 parts by volume of cold glacial acetic acid and mixed with 0.5 part by volume of a 32 percent solution of hydrogen bromide in glacial acetic acid. The mixture is maintained at 15 C. for 30 minutes and then poured into 500 parts by volume of ice-water containing 5 parts of potassium hydroxide.
  • the turbid solution is extracted with a total of 500 parts by volume of methylene chloride in 3 portions and the extracts are washed with sodium bicarbonate solution and water, dried and evaporated under reduced pressure in an atmosphere of nitrogen.
  • the residue is taken up in 35 parts by volume of ethanol of 95 percent strength and heated to 50 C. for 5 hours while stirring with 10 parts of Raney nickel catalyst.
  • the catalyst is filtered off and the filtrate evaporated to dryness.
  • On chromatographic purification over aluminum oxide there is obtained the pure 18,21-dibenzoate of 115,18-cyclosemiacetal of d,l- A -11B,17a,21-trihydroxy-3,18,2O-trioxo pregnene.
  • the dibenzoate thus obtained may be hydrolized as follows:
  • CHiOH O OH
  • CHaOH is purified by recrystallization from a mixture of acetone and ether. This compound is described in our copending 2.

Description

Unite States Patent STEROIDS AND PROCESS FOR MAKING SAME Tadeus Reichstein, Weissensteinstrasse 22, Basel, Switzerland; Stefan Antoni Szpilfogel, Prinses Beatrixlaan 10, Oss, Netherlands; and David Adriaan Van Dorp, Hertogm Johannasingel 17, Oss, Netherlands No Drawing. Filed Jan. 27, 1958, Ser. No. 711,163
Claims priority, application Switzerland Feb. 18, 1954 '3 Claims. (Cl. 260-3403) This is a continuation-in-part application of our patent application Serial No. 488,426, filed February 15, 1955 (now abandoned).
This invention provides a new D-homo-androstene compound, and derivatives thereof, as well as process for manufacturing same. More particularly this invention relates to the lactone of the 11 -11p-hydroxy-17-formyl- D-homo-androstadiene-Zi-one-18-acid of the formula:
and the functional derivatives thereof. Functional derivatives are those, which are formed with aldehydic and ketonic reagents, and are readily convertible into the compound of the above formula; more particularly acetals, ketals, e.g. ethylenedioxy derivatives, mercaptals, thioketals, enol derivatives, such as enol esters, enol ethers or enamines, hydrazones, semicarbazones, thiosemicarbazones, or the like.
The lactone of the A -11p-hydroxy-17-forrnyl-D- homoandrostadiene-3-one-18-acid, or the functional derivatives thereof are key intermediates in the preparation of therapeutically valuable compounds containing a formyl group in the 13-portion, such as aldosterone or the 17ot-hydroxylated derivative thereof, which is described in our copending application, Serial No. 711,164 concurrently filed herewith.
The new D-homo-androstene of the invention, or functional derivatives thereof may be converted into aldosterone according to the following procedure: After the D-homo-androstene compound has been converted into the 3-ethylenedioxy derivative thereof, in which the double bond in the 4-position is shifted into the 5-position, is, upon treatment of this 3-ethylenedioxy derivative of the lactone of A -llfi-hydroxy-l7-formyl-D-homo-androstadiene-3-one-l8-acid with sodium boron hydride, and esterification with benzoyl chloride, the benzoate .of the lactone of this compound is formed, which is further subjected to treatment with lithium aluminium hydride and esterification with benzoyl chloride. The thus ob tained dibenzoate of the 113,18-cyc1osemiacetal of A llfi-hydroxy 17 hydroxymethyl 18 oxo 3 ethylenedioxy D homo androstadiene is oxidized first with osmium tetroxide and then with periodic acid to the dibenzoate of the 218,4,3-cyclosemiacetal of 4bfi-methyl- 1p formylmethyl 25 formyl-2a(3 hydroxy 2' oxopropyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10, lOaa-dodecahydrophenanthrene-4B-ol. The formation of the latter may also be accomplished by treatment of the dibenzoate of the 115,18-cyclosemiacetal of A -IIp-hydroxy- 17 -hydroxymethyl-l 8-oxo-3-ethylenedioxy-D-homoice androstadiene with ozone, then with zinc in acetic acid! The ring closure to the dibenzoate of the 1:1fi,18-cyclosem1- acetal of A -11,6,2l-dihydroxy-l8,20-dioxo-3-ethylenedioxy-pregnadiene may be accomplished by treatment with piperidine in glacial acetic acid. Hydrogenation in the presence of a palladium-carbon catalyst removes the double bond in the l6-position and upon treatment with p-toluene sulfonic acid in acetone and, subsequently, with aquous potassium hydrogen carbonate, the M-llaZI-dihydroxy-3,18,20-tri0xo-pregnene or aldosterone is formed.
The A 11B,17oc,21 trihydroxy 3,18,20 trioxo-preg-, nene may be prepared according to the process described in our copending application, Serial No. 711,164, filed concurrently herewith, for example by treating the dibenzoate of the 11,8,18-cyclosemiacetal of A -115,21: dihydroxy 18,20 dioxo 3 ethylenedioxy pregnadiene, referred to above, withhydrogen peroxide, splitting the 16,17a-epoxide ring with hydrogen bromide and re moving the bromo atom in the 16-position by treatment with Raney nickel. The thus obtained dibenzoate of the 11,6,18-cyclosemiacetal of- A -11fl,17a,21-trihydroxy- 18,20-dioxo-3-ethylenedioxy-pregnene yields the desired carbonate.
A 11p,17a,21 trihydroxy 3,18,20 trioxo pregnene by treatment with p-toluene sulfonic acid and, subse: quently, with an aqueous solutionof potassium hydrogen The pregnene derivative thus obtained shows mineral corticoid properties.
The new lactone of A -11fl-hydroxy-l7-formyl-D- homoandrostadiene-3-one-18acid of this invention, or derivatives thereof may be prepared by treating the lactone of 4b? methyl 2B carboxy lfi formyl methyl 20a- (3' oxo propyl) 1,2,3,4,4aa,4b,5,6,7,9,10,10afi dodecahydrophenanthrene-4B-ol-7-one or a functional deriva-v tive thereof with ring closing reagent,-and, if desired, converting any res11lting,-functional derivative into the lactone of A -llB-hydroxy-l7formyl-D-homo-andror stadiene-S-one-lS-acid, and/or, if desired, converting the resulting lactone of A -1lfi-hydroxy-17-formyl-D-homoandrostadiene-Zl-one-l8-acid into a functional derivative.
Functional derivatives of the starting material are more especially acetals or ketals, such as the 7-ethylenedioxy derivative, in which the double bond in the 8-position is shifted into the 8a-position. 1
A reagent suitable for bringing about the closure of the ring, is particularly a mixture of piperidine with acetic acid.
The process of the invention may be carried out with racemates or optically active compounds. The racemates may be separated into their antipodes by methods, in themselves known, e.g. by chemical or micro-biological methods.
The lactone of 4bfi-methyl-2fl-carboxy-lfi-formyl: methyl 2a (3 oxo propyl) l,2,3,4,4aa,4b,5,6,7,9, l0,loafi-dodecahydrophenanthrene-4fl-ol-7-one or a functional derivative thereof used as the starting material in the above reaction may be prepared according to the following procedure: 4b[3-methyl-2-hydroxymethylene-7: ethylenedioxy 1,2,3,4,4,aa,4b,5,6,7,8,10,l0a18 dodecahy drophenanthrenetp-ol-l-one, when condensed with acrolein, yields the 4bB-methyl-2 3-formy1-2a-(3'-oxo-propyl)- 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10,10au dodeca: hydrophenanthrene-4B-o1-l-onc, which is converted into its 3,3'-dimethoxy-propylacetal by treatment with metha 1101 in the presence ofhydrogen chloride. Uponoxida; tion with a chromium trioxide-pyridine complex, the 25,4;8-1actone of 4bfi-methyl-2fi-carbon-2a-(3',3-dimeth: oxy propyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8, l0,10ap-dodecahydrophenanthrene-4fi-ol-l-one is formed,
which is reacted with lithium ethoxy-acetylene. The I 4aa,4b,5,6,7,8,10,10a;8 dodecahydrophenanthrene 1,4}3- diol formed is hydrogenated in the presence of a palladium catalyst and rearranged by dehydration with a solution of thionyl chloride in pyridine to the lactone of 4bfi methyl 2e carboxy 1,1 'formyl methylene- 2oz (3',3' dimethoxypropyl) 7 ethylenedioxy' 1,2,3, 4,4aa,4b,5,6,7,8,l0,la,8 7 dodecahydrophenanthrene 4/9- 01. Treatment with catalytically activated hydrogen and splitting of the acetal with hydrogen chloride in the presence of acetone yields the lactone of 4bB-methyl-2flcarboxy 1,3 formyl methyl 2oz (3'-oxo propyl)- 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10,10afi dodecahydrophenanthrene-4B-o1, which by reatment with ptoluene sulfonic acid in acetone may be converted into the lactone of 4be methyl-2p-carboxy-lp formylmethyl- 2m (3' oxo propyl) l,2,3,4,4aa,4b,5;6,7,9,10,10afidodecahydrophenanthrene-4 8-7-one. The starting material may also be used in the crude formwithout previous purification. Thus, by'treating, for example, the lactone of 4b 3 methyl 2/3 -'carboxy 1B formyl-methyl 2oz- 3,3' dimethoxy propyl) 7 ethylenedioxy 1,2,3,4, 4aa,4b,5,6,7,8,10,10ap -dodecahydrophenanthrene 4p 01 with an acetal splitting reagent, such as a hydrohalic acid, e.g. hydrogen chloride in acetone, the free aldehyde is obtained and is used without any further purification in the ring closure step.
The following examples illustrate the invention; the relationship of parts by'weight to parts 'by volume being the same as'that of the gram to the cubic centimeter.
Example 5 parts of the 'lactone of 4bB-methyl-2B-carboxy-1,3- formyl methyl 20c (3',3' dimethoxy propyl) 7- ethylenedioxy l,2,3,4,4aa,4b,5,6,7,8,10,10a/3 dodecahydrophenanthrene-4B-ol are dissolved in 250 parts by volume of dry acetone, and, after addition of 1.65 parts by volume of hydrochloric acid of 36 percent strength, stirred for 3 minutes at room temperature. The mixture is neutralized by the addition of 30 parts by volume of a l-molar aqueous sodium hydrogen carbonate solution, diluted with 2500 parts by volume of water, and thoroughly extracted with a mixture of methylene chloride and ether (1:3). The organic layer is washed with water, dried with'sodium sulfate, filtered and evaporated in vacuo to dryness. The oily residue, which isthe crude lactone of 4b,? methyl 2,3 carboxy 1B -formylmethyl 2o: (3- oxo-propyl) 7 ethylenedioxy 1,2, 3,4,4'aa,4b,5,6,7,'8,10,10ap dodecahydrophenanthrene- 4,6 0], is dissolved in 450 parts by volume of benzene, mixed with 12 parts by volume of glacial acetic acid and 9 parts by volume of piperidine, and boiled for 1 /2 hours in an atmosphere of nitrogen in an apparatus provided with a water-separator. After cooling, the solution is washed with Water, sodium hydrogen carbonate, and water, dried with sodium sulfate, and evaporated under reduced pressure. The residue is dissolved in benzene, and chromatographed over 150 parts of alumina. The combined benzene eluates yield the lactone of the d,l- A 11 9 hydroxy 3 ethylenedioxy 17 formyl- D-homo-androstadiene-l8-acid, which is recrystallized from a mixture of ether, and petroleum ether.
Upon treatment of 1 part of the above ketal with a solution of 0.2 part by weight of p-toluene sulfonic acid in 60 parts by volume of acetone for 12 hours at room temperature, and extraction of the reaction solution, after addition of a saturated solution of sodium chloride, with chloroform, the desired d,l-A -11B-hydroxy-17-formyl- D-homo-androstadiene-3-one-18 acid may be obtained.
The lactone of 4b 8-methyl-Zp-carboxy lfiformylmethyl 2oz (3,3' dimethoxy propyl) 7 ethylenedioxy l,2,3,4,4aa,4b,5,6,7,'8,10,10a/3 dodecahydrophe'nanthrene-4fl-ol used as the starting material, may beprepared as follows:
A suspension of 100 parts of 4b 3-methyl-2-hydroxymethylene 7 ethylenedioxy 1,2,3,'4,4au,4b,5,6,7,8,10,
4 10afl-dodecahydrophenanthrene-4fi-ol-1-one in 300 parts by volume of dioxane is mixed at room temperature with 75 parts by volume of freshly distilled acrolein, to which 0.125 part of hydroquinone has been added. The reaction mixture is stirred for 7 hours at room temperature, the whole being dissolved, and the solution is allowed to stand for another 16 hours. A solution of anhydrous methanolic hydrochloric acid of 1 percent strength is cautiously added dropwise while cooling with ice and stirring, until the reaction mixture has a pH value of 7.0.
750 parts by volume of methanol are then added, the mixture is stirred for 2 hours with cooling, the crystalline precipitate is filtered off, and washed on the filter with cold methanol. In this manner there are obtained 35 parts of 4bfl methyl 2/8 formyl 2a (3' 0x0- propyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10, 10afi dodecahydrophenanthrene-4/3-ol1-one melting at -177 C., which can be furtherpurified by recrystallization from benzene. The analytically pure product melts at 181 C.
.A suspension of 20.5 parts of 4bB-methyl-2B-formyl- 2a (3 oxo propyl) 7 ethylenedioxy 1,2,3,4,4aa, 4b,5,6,7,8,l0,l0a;3 dodecahydrophenanthrene 4/9 oll-one in 355 parts by volume of absolute methanol is gently heated on the water-bath with the exclusion of moisture, a clear solution being formed. The solution is cooled to 0 C. and 16.3 parts by volume of a solution of hydrochloric acid gas in absolute methanol containing 0.001 part of hydrochloric acid per part by volume, is added while stirring. The reaction mixture is stirred for half an hour at a temperature of 0 to +3 C., a crystalline precipitate slowly forming. The mixture is neutralized with a dilute solution of sodium methoxide in absolute methanol, the mixture is suction-filtered, and the crystals are Washed with cold methanol. By recrystallization from methanol or from a mixture of benzene and methanol there is obtained thepure 4bfi-methyl- 2B formyl 2a (3',3' -.dimethoxy propyl) 7 ethylenedioxy l,2,3,4,4a:z,4b,5,6,7,8,l0,10a,B dodecahydrophenanthrene-4 3-ol-1-one melting at 188 C.
3.5 parts of 4bfi-methyl-2'B-formyl-2u-(3,3-dimethoxypropyl)- 7 ethylenedioxy l,2,3,4,4aa,4b,5,6,7,8,10, lOafi-dodecahydrophenanthrene-4,6=ol-1one are dissolved in 2 parts by volume of dry pyridine and mixed at room temperature and with stirring with a chromium trioxidepyridine complex prepared from 3.5 parts of chromium trioxide and 10 parts by volume of dry pyridine. The suspension is stirred for 16 hours at room temperature, diluted with 50 parts by volume of benzene, the benzene solution is washed several times "with water and finally dried over sodium sulfate and evaporated to dryness in vacuo. The residue 'is recrystallized from methanol. There is obtained the lactone of 4bp-methyl-2fl-carboxy- 2a (3,3 dimethoxy propyl) 7 ethylenedioxy- 1,2,3,4,4au,4b,5,6,7,8,10,10afl dodecahydrophenanthrene-4fi-ol-1-one in colorless crystals which melt after recrystallization from methanol at 182 C. and in the infrared spectrum show an absorption band at 5.59 1. characteristic of a -lactone group.
To 3.47 parts of clean lithium Wire covered with 200 parts by volume of ether there areadded slowly dropwise with stirring in a dry atmosphere of nitrogen 26.25 parts by volume of freshly distilled bromobenzene. The reaction occurs With gentle boiling. As soon as all the bromobenzene has been added, the reaction mixture is boiled under reflux gently for 1 /2 hours, the lithium being completely consumed. The mixture is cooled to 0C. and slowly mixed with "a solution of 19.25 parts of freshly prepared ethoxy-acetylene in 60 parts by volume of absolute benzene free from thiophene. Thereupon the lithium-ethoxy-acetylene compound precipitates in the form of a White precipitate. The reaction mixture is slowly-heated to room temperature and mixed with a=solution-of 10l5 parts of the lactone of4b13-methylam ss 2B carboxy 2v. (3',3 dimethoxy propyl) 7 ethylenedioxy- 1,2,3,4,4aa,4b,5,6,7,8,10,10a,8-- dodecahydrophenanthrene-4fl-ol-1-one in 100 parts by volume of'dry benzene free from thiophene. The reaction mixture is stirred for 2 hours at room temperature under nitrogen, then'poured on to 1000 parts of ice water, thoroughly shaken and the aqueous phase extracted three times with 750 parts by volume of a mixture of benzene and ether (1:1) each time. The combined organic phases are washed with water until the reaction is neutral to litmus, dried with sodium sulfate, filtered and evaporated to dryness in vacuo. The oily residue is dissolvedin 45 parts by volume of ether. After being allowed to stand some time at room temperature crystals begin to'precipitate. After standing for 16 hours at 6 C. crystallization is complete. The crystalline precipitate is filtered with suction and washed on the filter with a mixture of petroleum ether and'ether (1:1). After recrystallization from ether there is obtained the pure lactone of 4bfi-methyl-2flcarboxy 113 ethoxy -ethinyl 2m (3,3 dimethoxypropyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10, 10a 8 dodecahydrophenanthrene 104,413 diol melting at 156-157 C. From the mother-liquor there is obtained by chromatography over alumina and elution with a petroleum ether ether mixture 1:1, thelactone of 4b}?- methyl 2B carboxy 1oz ethoxy ethinyl 20c (3,3- dimethoxy propyl) 7 ethylene dioxy 1,2,3,4,4aa, 4b,5,6,7,8,10,l0a;3 dodecahydrophenanthrene 15,45- diol, which on crystallisation from ether gives the'pure compound melting at 143 144 C.
A solution of 5 parts of the lactone of 4bp-methyl-2ficarboxy lfl ethoxy ethinyl 2m (3',3 dimethoxypropyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8,10, 1OaB-dodecahydrophenanthrene-lMAB-diol in 250 parts by volume of alcohol and 0.5 part by volume of pure pyridine is agitated in the presence of 0.25 part of a palladium calcium carbonate catalyst of 10 percent strength in an atmosphere of hydrogen at room temperature. After one molecular equivalent of hydrogen has been taken up, the reaction ceases. The mixture is filtered from the catalyst, through a thin layer of Super Cel, the filter is washed with alcohol, and the filtrate is evaporated to dryness under reduced pressure. The crystalline residue is recrystallized from a mixture of ethyl acetate and petroleum ether. The resulting lactone of 4b1S-methyl-2B- carboxy 1;? ethoxy vinyl 20c (P/,3 dimethoxypropyl) 7 ethylenedioxy 1,2,3,4,4au,4b,5,6,7,8,10, 10a,8 dodecahydrophenanthrene 111,4 3 diol melts at 184-186 C.
A solution of 3.3 parts of the lactone of 4b,8-methyl- 25 carboxy 1B ethoxy vinyl 2a (3,3' dimethoxy propyl) 7 ethylenedioxy 1,2,3,4,4aa,4b,5,6,7,8, 10,10a/8 dodecahydrophenanthrene 10:,45 diol in 135 parts by volume of anhydrous pyridine is mixed with .38 parts by volume of a 2-molar solution of purest thionyl chloride in anhydrous pyridine at C. in an atmosphere of nitrogen in the course of 2 minutes. After stirring for 15 minutes at 0 C. the reaction mixture is poured on to 700 parts by volume of a cold 0.5-molar solution of sodium hydrogen carbonate and washed with 1000 parts by volume of methylene chloride. The .mixture is thoroughly agitated and the organic layer is washed with icecold 0.5-molar sodium hydrogen carbonate solution and with cold water, dried with sodium sulfate, and after filtration'the solution is evaporated .to dryness under reduced pressure. By crystallizing the residue from ether there is obtained the lactone of 4bfi-methyl-2fi-carboxy- 1,1 formyl methylene 2a (3',3' dimethoxy propyl) 7 ethylenedioxy 1,2,3,4aa,4b,5,6,7,8,10,10afidodecahydrophenanthrene-4B-ol melting at 206 -207 C. which in the ultra-violet spectrum shows an absorption maximum at 236 mu (log=3.85).
3.75 parts of this lactone are dissolved in 100 parts by volume of alcohol and inithe presence of 1.1 parts of a palladium barium sulfate catalyst of percent strength agitated at room temperature in an atmosphere. of hydrogen. ,After 0.97 molecular equivalent of hydrogen has been taken up the reaction is interrupted. The mixture is filtered off from the catalyst and the filtrate is .evaporated in,vacuo. From the residue there is obtained by crystallization from a mixturerof ether and, petroleum ether the lactone of 4bfl-methyl-2B-carboxy-1,8-formylmethyl 2a (3",3', dimethoxy-propyl) .7.- ethylenedioxy .1,2,3,4,4a0! ,4b,5,6,7,8,10,10313,- dodecahydrophenanthrene-4B-ol, meltingat 188189 C. I
The lactone of the d,l-A -l1fihydroxy-l7-formyl D- homo-androstadiene-3-one-l8-acid of this invention or a functional derivative. thereof may be converted into ,aldosterone according to the following method: A solution of 6.2 parts of the lactone of d,l-A -'llB-hydroxy-Ii-ethylenedioxy 17 -,formy1 D homo androstadiene 18- acid in 200 parts by volume of alcohol is stirred for 16. hours at room temperature after the addition of 0.8 part of sodium boron hydride. By the cautious addition of 2 parts by volume of glacial acetic acid the excess of the reducing agent is destroyed, the mixture is diluted with 2000 parts by volume of water and extracted 3 times with 250 parts by volume of methylene chloride each time. The methylene chloride solution is washed with water, dried with sodium sulfate, filtered and evaporated. The dry residue is dissolved in 24 parts by volume of anhydrous pyridine and slowly mixed with 2.9 parts by volume of freshly distilled benzoyl chloride at 5 C. withstirring and the exclusion of moisture, care being taken that the temperature does not rise above 7 C. Stirring is continued for a half an hour at 5 C. and then the temperature is allowed to rise slowly to room temperature. After 16 hours the mixture is poured on to 340 parts by volume of ice water and washed with 100 parts by volume of methylene chloride. The mixture is extracted twice more with 150 parts by volume of methylene chloride each time, the extracts are washed with cold l-molar sodium hydrogen carbonate solution, water, dilute hydrochloric acid and again with Water, dried with sodium sulfate and evaporated in vacuo. The residue is dissolved in 20 parts by volume of benzene and after a short treatment with active charcoal is filtered through a small column of alumina. From the filtrate there is obtained after concentration and mixing with petroleum ether the benzoate of lactone of d,l-A -llfi-hydroxy-3 ethylenedi oxy 17 hydroxymethyl D homo androstadiene-18- acid which is purified by crystallization from a mixture of acetone and water. I
To a solution of 4.9 parts of the benzoate of lactone of d,l-A 11,8 hydroxy 3 ethylenedioxy 17 hydroxymethyl D homo androstadiene 18 acid in 27 parts by volume of tetrahydrofurane is added dropwise a solution of 0.21 part of lithium aluminum hydride in tetrahydrofurane at 15 C. with stirring. During this operation the temperature is kept below 10 C. After the reagent has been added (about 30 minutes), the reaction mixture is slowly allowed to heat up to room temperature, is cooled again to 0 C. and cautiously mixed with 10 parts by volume of acetone. About two-thirds of the solvent are now evaporated under reduced pres.- sure, the residue is poured on to 200 parts of ice and the cold mixture is acidified with 6 parts by volume of glacial acetic acid. The mixture is rapidly extracted three times with 100 parts by volume of methylene chloride each time, the extracts are washed with water untilthe reaction is neutral to litmus, dried with sodium sulfate and evaporated in vacuo. The dry residue is dissolved in 13 parts by volume of anhydrous pyridine and mixed with 1.3 parts by volume of freshly distilledbenzoyl chloride at 5 C. with stirring and the exclusion of moisture The temperature is allowed to rise slowly to room tempera:
ture. After 16 hours the mixture is poured on to 200 parts by volume of ice Water and washed with .-50 p arts by volume of methylene chloride. The mixturevis extracted twice more with parts by volume of methylene chloride each time, the extracts are washed with cold 1- molar sodium hydrogen carbonate solution, water, dilute hydrochloric acid and again with water, dried with sodium sulfate and evaporated in vacuo. The residue is dissolved in 20 parts by volume of benzene and after a short treatment with active charcoal is filtered through a small column of alumina. The solvent is evaporated and the crude product purified by chromatography over alumina (activity H) yields from the benzene eluates the dibenzoate of 115,18-cyclo-semiacetal of d,l-A -1lt?-hydroxy 17 hydroxy methyl l8 oxo 3 ethylenedioxy-D-homo-androstadiene, which can be purified by chromatography.
2.4 parts of this dibenzoate are dissolved in 235 parts by volume of ethyl acetate, cooled to 3.0 C. and a dry current of oxygen containing ozone is passed through this solution until about 1.05 molar equivalents of ozone have been consumed. 14 parts by volume of glacial acetic acid are added and 20 grams of zinc dust are added to the solution in portions while stirring. After one hour the solution is filtered ofi from the zinc and zinc salts and the ethyl acetate solution is washed with sodium hydrogen carbonate solution of 5 percent strength and water. After drying the ethyl acetate solution with sodium sulfate, filtering and evaporating under reduced pressure to dryness, the crude reaction product is subjected to ring closure by boiling a solution in 450 parts by volume of benzene, mixed with 12 parts by volume of glacial acetic acid and 9 parts by volume of piperidine, for one and one half hours in an atmosphere of nitrogen in an apparatus provided with a water separator. After cooling, the solution is washed with water, sodium hydrogen carbonate and water, dried over sodium sulfate and evaporated under reduced pressure. After purification by chromatography there is obtained the 18,21-dibenzoate of 11,3,18-cyclosemiacetal of d,l-A -11 8,21- dihydroxy-l8,20-dioxo-3-ethylenedioxy-pregnadiene.
1 part of the compound so obtained is dissolved in 50 parts by volume of pure methanol and, after the addition of a solution of 0.01 part of potassium hydroxide in parts by volume of methanol and 1 part of a 2 percent palladium-carbon catalyst, the mixture is agitated in an atmosphere of hydrogen until 1 mol of hydrogen has been taken up. The catalyst is removed by filtration, washed with methanol, the solution is neutralized by the addition of 0.01 part of glacial acetic acid and concentrated by evaporation in vacuo. The residue is taken up in chloroform, the chloroform solution is washed with water, dried with sodium sulfate and evaporated to dryness in vacuo. From the residue there is obtained by crystallization the 18,2l-dibenzoate of the llB-18-cyclosemiacetal of d,l-A -11B,21 dihydroxy 18,20-dioxo-3- ethylenedioxy-pregnene.
1 part of the dibenzoate-ketal is mixed with a solution of 0.2 part of p-toluene sulfonic acid in 60 parts by volume of acetone, and the whole is stirred overnight. After the addition of a saturated solution of sodium chloride and extracting by agitation with chloroform, the chloroform solutions are dried and evaporated, and there is obtained from the residue the 18,21-dibenzoate of the 1119,18-cyclosemiacetal of d,l-l 8-oxo-corticosterone.
1.2 parts of the dibenzoate are mixed with 190 parts by volume of methanol, and then a solution of 1.9 parts of potassium bicarbonate in 45 parts by volume of water is added in a current of nitrogen While stirring. The reaction solution is allowed to stand in a closed vessel under reduced pressure for 3 days at 20 C. The solution is concentrated to a considerable extent in vacuo in a current of nitrogen at a bath temperature of 40 C, and the aqueous residue is extracted with 4 portions each of 40 parts by volume of a mixture of chloroform and ether (1 :3). The organic solution is washed with water, dried and evaporated. The resulting d,l-l8-oxo-corticosterone or aldosterone is purified by crystallization from a mixture of acetone and ether.
Instead of reducing the double bond in the l6-position of the 11,8,18-cyc1osemiacetal of d,l-A -11;5',21-dihydroxy-18,20-dioxo 3 ethylenedioxy pregnadiene described hereinabove the latter may be converted as follows:
1 part of the dibenzoate of 115,18-cyclosemiacetal of d,l-A -l1fi,21-dihydroxy 18,20-dioxo-3 ethylenedioxypregnadiene is dissolved in parts by volume of methanol and treated with a solution of 0.2 part of potassium carbonate in 2 parts by volume of water and with 5 parts by volume of a hydrogen peroxide solution of 30 percent strength. The reaction mixture is allowed to stand at 0 C. for 48 hours, 2 parts of solid potassium monophosphate are then added and the mixture is concentrated at a bath temperature of 25 C. until about 20 parts by volume are left. The residue is mixed with 100 parts by volume of water and extracted with a total of 200 parts by volume of methylene chloride in 3 portions. The extracts are thoroughly washed with water, dried and evaporated.
The crude, partially saponified product thus obtained is rebenzoylated with pyridine and benzoyl chloride with the use of chloroform as diluent. The resulting dibenzoate of 11,53,18-cyc1osemiacetal of d,l-A -ll;3,21-dihydroxy-I6,17a-oxido-18,20-dioxo 3 ethylenedioxy pregnene is dissolved in 50 parts by volume of cold glacial acetic acid and mixed with 0.5 part by volume of a 32 percent solution of hydrogen bromide in glacial acetic acid. The mixture is maintained at 15 C. for 30 minutes and then poured into 500 parts by volume of ice-water containing 5 parts of potassium hydroxide. The turbid solution is extracted with a total of 500 parts by volume of methylene chloride in 3 portions and the extracts are washed with sodium bicarbonate solution and water, dried and evaporated under reduced pressure in an atmosphere of nitrogen. The residue is taken up in 35 parts by volume of ethanol of 95 percent strength and heated to 50 C. for 5 hours while stirring with 10 parts of Raney nickel catalyst. The catalyst is filtered off and the filtrate evaporated to dryness. On chromatographic purification over aluminum oxide there is obtained the pure 18,21-dibenzoate of 115,18-cyclosemiacetal of d,l- A -11B,17a,21-trihydroxy-3,18,2O-trioxo pregnene. The dibenzoate thus obtained may be hydrolized as follows:
1.2 parts of the dibenzoate are mixed with palts by volume of methanol, and then a solution of 1.9 parts of potassium bicarbonate in 45 parts by volume of water is added in a current of nitrogen While stirring. The reaction solution is allowed to stand in a closed vessel under reduced pressure for 3 days at 20 C. The solution is concentrated to a considerable extent in vacuo in a current of nitrogen at a bath temperature of 40 C., and the aqueous residue is extracted with 4 portions each of 40 parts by volume of a mixture of chloroform and ether (1:3). The organic solution is washed with water, dried and evaporated. The resulting d,l-A -11,8,17a,2l-trihydroxy-3,l8,20-trioxopregnene or its 11B,18-cyclosemiace' tal of the formulae:
CHiOH O=OH CHaOH is purified by recrystallization from a mixture of acetone and ether. This compound is described in our copending 2. The lactone of A -11B-hydroxy-17-formy1-D homo-androstadiene-3-one-18-acid.
3. The lactone of A -1lfi-hydroxy-B-ethylenedioxy- 17-formyl-D-homo-androstadiene-1S-acid.
liatent application Serial No. 711,164, filed concurrently herewith.
What is claimed is:
1. A member of the group consisting of the lactone of A -1lfl-hydroxy-l7-formy1-D-homo androstadiene 3- 5 0ne-18-acid and the S-ketal with lower alkylene glycol. N0 ces c

Claims (1)

1. A MEMBER OF THE GROUP CONSISTING OF THE LACTONE OF $4,16-11B-HYDROXY-17-FORMYL-D-HOMO-ANDROSTADIENE -3ONE-18-ACID AND THE 3-KETAL WITH LOWER ALKYLENE GLYCOL.
US711163A 1954-02-18 1958-01-27 Steroids and process for making same Expired - Lifetime US2948738A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2948738X 1954-02-18

Publications (1)

Publication Number Publication Date
US2948738A true US2948738A (en) 1960-08-09

Family

ID=4572964

Family Applications (1)

Application Number Title Priority Date Filing Date
US711163A Expired - Lifetime US2948738A (en) 1954-02-18 1958-01-27 Steroids and process for making same

Country Status (1)

Country Link
US (1) US2948738A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072645A (en) * 1959-09-04 1963-01-08 Ciba Geigy Corp 17alpha:21-dihydroxy-20-ketones of the pregnane series and process for their manufacture
US3216997A (en) * 1963-05-23 1965-11-09 Schering Corp 17alpha-hydroxyaldosterones and processes for their manufacture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072645A (en) * 1959-09-04 1963-01-08 Ciba Geigy Corp 17alpha:21-dihydroxy-20-ketones of the pregnane series and process for their manufacture
US3216997A (en) * 1963-05-23 1965-11-09 Schering Corp 17alpha-hydroxyaldosterones and processes for their manufacture

Similar Documents

Publication Publication Date Title
US2948738A (en) Steroids and process for making same
US3247189A (en) 3, 19 and 20 oxygenated-delta5-pregnenes
US2904545A (en) 21-diazo pregnenes
Fieser et al. Identification of Ketone 104 as 3, 4-Secocholestane-6-one-(3α, 5α)(3β, 4)-dioxide
FRIED et al. STUDIES ON LACTONES RELATED TO THE CARDIAC AGLYCONES. VII. SYNTHESIS OF 3, 14-BISDESOXYTHEVETIGENIN AND OF 14-DESOXYTHEVETIGENIN
US2897219A (en) delta5-20-keto-3:16:21-trihydroxy-pregnenes and esters thereof
SU439973A1 (en) Method for preparing methyl 19-norprogesterone derivative
US2994694A (en) 18-oxygenated steroids and process for their synthesis
Bernstein et al. Steroidal Cyclic Ketals. XIII. 1 The Conversion of 11-epi-Corticosterone into Corticosterone
US2847457A (en) Steroid intermediates
US3096350A (en) 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof
Mancera et al. Steroids. LXX. 1 Removal of the 17-Hydroxyl Group from 17α, 21-Dihydroxy-20-ketopregnane Derivatives2
US2986567A (en) New hydrophenanthrene compounds
US3032563A (en) 16-ethynylated steroid compounds and process for their production
US3272797A (en) Cyclic acetals and ketals of the 6alpha-methylpregnane series and process for preparing same
US2404768A (en) Alpha-substituted side-chain ketones of the cyclopentanopolyhydrophenanthrene series
US2859212A (en) 21-aldo steroids
US3365474A (en) Polyhydroxypregn-7-enes and processes for their preparation
US2479966A (en) Ring-c unsaturated alpha-substituted side-chain steroid ketones and process
US3014028A (en) 18-nor-steroids
US2704768A (en) 17-(beta-hydroxyethylidene)-13-methyl-1, 2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17-tetradecahydro-15h-cyclopenta [a] phenanthren-3-one and esters thereof
US3085089A (en) 11, 18; 18:20-bis-oxido-pregnenes and process for the preparation thereof
US3083198A (en) Novel 2-alkoxy steroids and processes for preparing the same
US3080381A (en) Optionally 6-methylated and optionally 17-alkanoyloxygenated 2-oxapregnane-3, 20-diones, a-homo compounds corresponding, and 4, 5-dehydro and 4, 5; 6, 7-bisdehydro derivatives thereof
US3087941A (en) 17alpha-bromo-6-methyl-pregnane derivatives